Radiosynthesis and First Preclinical Evaluation of the Novel (11)C-Labeled FAP Inhibitor (11)C-FAPI: A Comparative Study of (11)C-FAPIs and ((68)Ga) Ga-DOTA-FAPI-04 in a High-FAP-Expression Mouse Model

新型<sup>11</sup>C标记FAP抑制剂<sup>11</sup>C-FAPI的放射合成及首次临床前评价:<sup>11</sup>C-FAPI与<sup>68</sup>Ga-DOTA-FAPI-04在高FAP表达小鼠模型中的比较研究

阅读:1

Abstract

PURPOSE: (68)Ga-labeled fibroblast activation protein inhibitors, such as [(68)Ga]Ga-DOTA-FAPI-04 and [(68)Ga]Ga-DOTA-FAPI-46, have been successfully applied in positron emission tomography imaging of various tumor types. To broaden the PET tracers of different positron nuclides for imaging studies of FAP-dependent diseases, we herein report the radiosynthesis and preclinical evaluation of two (11)C-labeled FAP inhibitors, (11)C-RJ1101 and (11)C-RJ1102. METHODS: Two phenolic hydroxyl precursors based on a quinoline amide core coupled with a 2-cyanopyrrolidine moiety were coupled with [(11)C]CH(3)I to synthesize (11)C-RJ1101 and (11)C-RJ1102. In vivo small-animal PET and biological distribution studies of (11)C-RJ1101 and (11)C-RJ1102 compared to [(68)Ga]Ga-DOTA-FAPI-04 were conducted in nude mice bearing U87MG tumor xenografts at 30, 60, and 90min, respectively. RESULTS: (11)C-RJ1101 and (11)C-RJ1102 were synthesized in over 15% radiochemical yields, with specific activities of 67 GBq/μmol and 34 GBq/μmol, respectively, at the end of synthesis and radiochemical purities greater than 99%. In U87MG tumor xenograft PET studies, the three tracers experienced higher specific uptake at the tumor site. However, because of significant differences in metabolism and clearance, [(68)Ga]Ga-DOTA-FAPI-04 experienced high uptake in the kidney, whereas (11)C-RJ1101 and (11)C-RJ1102 showed high uptake in the liver and intestine. Biodistribution studies revealed significant hepatobiliary excretion of (11)C-RJ1101 and (11)C-RJ1102. 11C-RJ1102 showed higher specific tumor uptake in U87MG xenografts (1.71 ± 0.08% injected dose per Gram of tissue [ID/g]) than (11)C-RJ1101 (1.34 ± 0.10%ID/g) and [(68)Ga]Ga-DOTA-FAPI-04 (1.29 ± 0.04%ID/g) after 30 min p. i. In orthotopic glioma models, the uptake values were 0.07 ± 0.03% ([(68)Ga]Ga-DOTA-FAPI-04) and 0.16 ± 0.03% ((11)C-RJ1102), respectively. CONCLUSION: (11)C-RJ1101 and (11)C-RJ1102 are interesting candidates for translation to the clinic, taking advantage of the shorter half-life and physical imaging properties of C-11.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。